Delivery Order SPE2DB24D2010-SPE2DB25FABCM
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Xifaxan 550 mg tablets (60-count units) under a firm fixed-price contract valued at $2,392.21. The order carries an ultimate completion date of September 9, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Xifaxan 550 mg tablets (60-count units) with a contract value of $4,557.98. This firm fixed-price delivery order, with an ultimate completion date of July 30, 2025, represents a non-set-aside, competitively awarded procurement supporting federal medical supply needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Xifaxan 550 mg tablets (60-count units) with a ceiling value of $28,942.08. This firm fixed-price delivery order, which is expected to be completed by August 25, 2025, was competitively awarded with no set-aside designation. The work will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, where the company maintains operations as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Xifaxan 550 mg tablets (60-count units) under a firm fixed price contract valued at $12,267.73. This non-set-aside competitive award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The ultimate completion date...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Xifaxan 550 mg tablets (60-count units) with a ceiling value of $6,558.15. This is a firm fixed price delivery order with an ultimate completion date of June 20, 2025, and carries no set-aside designation, indicating it was awarded through competitive procedures. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Xifaxan 550 mg tablets in a quantity of 60 units, with a ceiling value of $16,598.12. This firm fixed-price delivery order is part of a competitive procurement with no set-aside designation and is scheduled for completion by September 10, 2025. The place of performance is AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Xifaxan 550 mg tablets (60-count) with a ceiling value of $8,948.63. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is set for ultimate completion by September 11, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Xifaxan 550 mg tablets (60-count packages) under a firm fixed price contract valued at $4,888.67. This competitively awarded delivery order, with no set-aside designation, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Xifaxan 550 mg tablets (60-count units) with a ceiling value of $1,594.13. This firm fixed-price delivery order, with an ultimate completion date of August 8, 2025, is performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award was made through competitive procedures with no set-aside designation, reflecting the contractor's demonstrated...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Xifaxan 550 mg tablets (60-count units) with a ceiling value of $7,597.68. This is a firm fixed-price delivery order with no set-aside designation, indicating it was awarded through open competition. The order is scheduled for ultimate completion on August 28, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken,...
- SPE2DB24D2010Indefinite Delivery Contract
- SPE2DB24D2010-SPE2DB25FABCMDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Xifaxan 550 mg tablets (60-count packages) under a firm fixed-price contract with a ceiling value of $27,314.07. This is a non-set-aside award issued as a child order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The order is scheduled for ultimate completion on September 9, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a continuation of AmerisourceBergen Drug Corp's substantial pharmaceutical supply role supporting federal military and veteran healthcare systems. As a major pharmaceutical distributor, AmerisourceBergen holds an IDC valued at $999,999,999.00 with DLA Troop Support Medical (SPE2DX) through December 2026, which serves as the overarching contract vehicle enabling the company to fulfill diverse pharmaceutical procurement needs globally. The Xifaxan supply supports the broader Defense Health Agency medical supply chain and demonstrates the contractor's capability to deliver specialized pharmaceutical products as part of its comprehensive federal healthcare support mission.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $27.3k | 9/8/25 |